Effect of dexamethasone and hyaluronic acid combination on Meniere's disease
Phase 3
- Conditions
- Meniere's disease.Meniere's disease
- Registration Number
- IRCT20130311012782N25
- Lead Sponsor
- Esfahan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 25
Inclusion Criteria
Patients with Meniere's disease
Patients resistant to other treatments such as lifestyle modifications, vasodilators or diuretics during the last 6 months
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Hearing impairment. Timepoint: Before the intervention and 2 weeks after the treatment. Method of measurement: Speech discrimination score.;Vertigo. Timepoint: Before the intervention and 2 weeks after the treatment. Method of measurement: Dizziness Handicap Inventory.;Tinnitus. Timepoint: Before the intervention and 2 weeks after the treatment. Method of measurement: Tinnitus Handicap Inventory.
- Secondary Outcome Measures
Name Time Method